Breaking News on Supplements & Nutrition - North AmericaEU edition
Diabetes
Diabetes affects over 220 million people globally and the consequences of high blood sugar kill 3.4 million every year, according to the World Health Organisation (WHO). If such statistics weren’t scary enough, the WHO is predicting deaths to double between 2005 and 2030.
But what is this condition, how can diet and nutrition help, and do consumers understand 'healthy blood glucose'? In this four-part special edition, NutraIngredients-USA investigates the link between nutrition and this pandemic.
Diabetes: From ancient Egypt to modern pandemic
It has been called a pandemic and a silent killer: Diabetes is a growing specter for public health agencies across the world. In the first part of our special series on diabetes, NutraIngredients examines the underlying condition and gets a grip on how big the issue is.
How can nutrition aid diabetes management?
Diabetes affects more than 220 million people globally and the consequences of high blood sugar kill 3.4 million every year. In the second part of our special series on diabetes, NutraIngredients looks at the role of nutrition and diet in managing, and potentially reversing diabetes.
Can dietary interventions treat diabetes' deathly global heathcare burdens?
As the previous three articles in this series have highlighted, dietary interventions that can combat the rise of diabetes and obesity are numerous and plentiful, as is the growing body of science backing their efficacy, from herbs to vitamins, proteins and more.
How do you sell healthy blood glucose to consumers?
While a dietary solution to the ticking time bomb of type 2 diabetes would appear to have huge commercial potential, the US market for foods and supplements that keep our blood glucose levels healthy has yet to set the world on fire.
Spotlight
  Vitamin Shoppe: US supplement user confidence soars to 93% as usage increasesTaking dietary supplements can boost confidence about health, according to The Vitamin Shoppe's annual survey, with usage... |
 NBTY: ‘DMAA-containing products represent less than 0.5% of our sales’The FDA crackdown on stimulant DMAA will not have a big impact on supplements giant NBTY, said... |
 Dispatches from AHPA's Botanical CongressFDA: We’re not enforcing NDI draft guidance; GMPs are the biggest issueThe Food & Drug Administration is not preparing to enforce its controversial draft guidance on new dietary... |
 Vitamin Shoppe boss quizzed on DMAA on Q1 earnings callVitamin Shoppe boss Tony Truesdale would not say how much the FDA crackdown on DMAA is likely... |